ANTIPODES PARTNERS Ltd: MSFT position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on MSFT, newest first. How the timeline and the estimate are built.
ANTIPODES PARTNERS Ltd held 394,726 MSFT shares at 2026-06-30 per its 13F-HR filed 2026-08-06.
the latest 13F is the newest step
- period ended2026-06-3013F 394,726 sharesChange vs previous 13F -136,999 shares
2.7% of the 13F portfolio, value $147,240,692.
13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 531,725 sharesChange vs previous 13F +114,810 shares
3.79% of the 13F portfolio, value $196,828,643.
13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 416,915 sharesChange vs previous 13F +116,568 shares
4.23% of the 13F portfolio, value $201,643,550.
13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 300,347 sharesChange vs previous 13F -179,607 shares
3.49% of the 13F portfolio, value $155,576,465.
13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 479,954 sharesChange vs previous 13F -28,324 shares
7.4% of the 13F portfolio, value $238,752,133.
13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 508,278 sharesChange vs previous 13F +67,463 shares
5.98% of the 13F portfolio, value $190,817,788.
13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 440,815 sharesChange vs previous 13F +197,740 shares
6.46% of the 13F portfolio, value $185,818,527.
13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 243,075 sharesChange vs previous 13F not available
3.63% of the 13F portfolio, value $104,602,711.
13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).